You have 9 free searches left this month | for more free features.

CAPTEM

Showing 1 - 13 of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,

Recruiting
  • Neuroendocrine Tumor Grade 2
  • Liver Metastases
  • Capecitabine tablets + temozolomide tablets + SIR-Spheres
  • Philadelphia, Pennsylvania
    Abramson Cancer Center
Oct 1, 2021

Glioblastoma Multiforme (GBM), Glioblastoma, Glioma of Brain Trial in New York (Capecitabine, Temozolomide)

Recruiting
  • Glioblastoma Multiforme (GBM)
  • +8 more
  • New York, New York
    Lenox Hill Brain Tumor Center
Aug 30, 2021

Metastatic Colorectal Cancer Trial in Milan (Capecitabine, Temozolomide, Irinotecan)

Completed
  • Metastatic Colorectal Cancer
  • Milan, Mi, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Sep 3, 2021

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,

Recruiting
  • Neuroendocrine Tumor Grade 2
  • Neuroendocrine Tumors
  • Capecitabine Oral Product
  • +2 more
  • Little Rock, Arkansas
  • +2 more
Aug 11, 2022

Neuroendocrine Carcinoma Trial in Italy (CPT-11, Calcio levofolinate, 5-Fluorouracil)

Recruiting
  • Neuroendocrine Carcinoma
  • Ancona, AN, Italy
  • +22 more
Feb 25, 2021

Neuroendocrine Tumors Trial in Warszawa (177Lu-DOTATOC)

Unknown status
  • Neuroendocrine Tumors
  • Warszawa, Poland
    Centrum Diagnostyczno-Lecznicze Gammed
Nov 2, 2020

Neuroendocrine Tumors Trial in Worldwide (177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, CAPTEM (Capecitabine

Recruiting
  • Neuroendocrine Tumors
  • 177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT
  • +4 more
  • Palo Alto, California
  • +30 more
Dec 14, 2022

Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

Active, not recruiting
  • Neuroendocrine Tumors
  • Oxaliplatin-based chemotherapy
  • Alkylating-based chemotherapy
  • Amiens, France
  • +18 more
Mar 15, 2022

Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,

Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • Unresectable Pancreatic Neuroendocrine Carcinoma
  • Lutetium Lu 177 Dotatate
  • +4 more
  • (no location specified)
Feb 10, 2022

Metastatic Colorectal Cancer Trial in Milan (Bevacizumab, Irinotecan, Leucovorin)

Recruiting
  • Metastatic Colorectal Cancer
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022

Rectal Cancer Trial in Milan (External-beam radiation, Capecitabine, Temozolomide)

Recruiting
  • Rectal Cancer
  • External-beam radiation
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Jan 25, 2022

Neuroendocrine Tumors Trial in Beijing (Capecitabine, Dacarbazine, Capecitabine, Temozolomide)

Unknown status
  • Neuroendocrine Tumors
  • Capecitabine, Dacarbazine
  • Capecitabine, Temozolomide
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Sep 10, 2017